Why is Bruker (BRKR) stock down today?

Bruker Corporation shares fell roughly 22% to $50.30 on August 4, 2026 — from a previous close of $64.31 — after the company reported second-quarter 2026 results that included a full-year revenue outlook cut. While adjusted earnings per share came in at $0.31, topping the consensus estimate of roughly $0.23, revenue for the quarter came in below analyst estimates. The revenue miss and the lowered full-year 2026 revenue guidance were the dominant forces driving the sell-off: when a company guides annual revenue lower, it signals weaker demand ahead, prompting investors to reprice the stock sharply downward.

The guidance cut stood out as the sharper blow because it was not fully offset by the earnings beat. Adjusted full-year earnings guidance for 2026 also fell slightly short of Wall Street estimates, compounding the negative reaction. A web search item noted that margin risks and helium supply risks are also part of the shifting narrative around Bruker, adding to concerns about the company's cost structure and operational outlook.

The broader market provided no cover for Bruker's decline. The S&P 500 rose 1.79% and the Nasdaq-100 (tracked by QQQ) surged 3.40% on the same day, with the S&P 500 and Dow Jones hitting record highs — meaning Bruker's drop was entirely company-specific and stood in stark contrast to a broadly rising market. The stock's 22% single-day decline is severe even by its own historical standards; one source noted Bruker has had 30 moves greater than 5% over the past year, but today's move indicates the situation is particularly acute.

As of the close of trading on August 4, 2026, Bruker shares traded at $50.30, down from a session high of $56.37, with the intraday low touching $50.12. The company's market capitalization stands at approximately $7.66 billion. The lowered revenue outlook remains the central unresolved concern heading into future quarters.